{"code":"E71.51","type":"code","title":"Disorders of peroxisome biogenesis","codeAlso":[],"includes":[],"modern_v":"official26","codeFirst":[],"excludes1":["Refsum's disease (G60.1)","Schilder's disease (G37.0)","androgen insensitivity syndrome (E34.5-)","congenital adrenal hyperplasia (E25.0)","hemolytic anemias attributable to enzyme disorders (D55.-)","Marfan syndrome (Q87.4-)","5-alpha-reductase deficiency (E29.1)"],"excludes2":["Ehlers-Danlos syndromes (Q79.6-)"],"isBillable":false,"sibling_codes":["E71.510","E71.511","E71.518"],"inclusionTerms":["Group 1 peroxisomal disorders"],"sibling_titles":{"code":"E71.518","title":"Other disorders of peroxisome biogenesis","isBillable":true},"useAdditionalCode":[],"clinicalDefinition":"Disorders of peroxisome biogenesis is a non-billable ICD-10-CM category code (E71.51). A more specific billable subcode must be selected for claims submission. Inclusion terms: Group 1 peroxisomal disorders. Excludes1 (not coded here): Refsum's disease (G60.1); Schilder's disease (G37.0); androgen insensitivity syndrome (E34.5-); congenital adrenal hyperplasia (E25.0); hemolytic anemias attributable to enzyme disorders (D55.-); Marfan syndrome (Q87.4-); 5-alpha-reductase deficiency (E29.1). Excludes2 (not included here): Ehlers-Danlos syndromes (Q79.6-).","officialDefinition":"Disorders of peroxisome biogenesis is a non-billable ICD-10-CM category code (E71.51). A more specific billable subcode must be selected for claims submission. Inclusion terms: Group 1 peroxisomal disorders. Excludes1 (not coded here): Refsum's disease (G60.1); Schilder's disease (G37.0); androgen insensitivity syndrome (E34.5-); congenital adrenal hyperplasia (E25.0); hemolytic anemias attributable to enzyme disorders (D55.-); Marfan syndrome (Q87.4-); 5-alpha-reductase deficiency (E29.1). Excludes2 (not included here): Ehlers-Danlos syndromes (Q79.6-).","seventhCharacterInstructions":[],"workflowProtocols":[],"guidelines":{"whenToUse":[],"whenNotToUse":[],"commonBillingMistakes":[],"codeComparisons":[],"documentationChecklist":[]},"domainLandscape":{"summary":"Primary diagnostic domain and clinical landscape evaluation.","keyCategories":[],"diagnosticContinuum":"Progression continuum from acute presentation to resolution."},"children":[],"hierarchy":[],"relatedCodes":[],"relevantCPTCodes":[],"documentationTips":[],"caseStudies":[],"description":"","overview":""}